July 10, 2025 · Form 4 insider transaction
Versant Venture Capital VI, L.P. sold 191,376 shares of LENZ Therapeutics, Inc. at $34.00 per share, a transaction worth $6.51M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
These shares are held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.